you're one of those that got in at 137. CELG has a VERY hard time holding onto a one day gain of 7 plus. Better to sell and buy back a couple days later at a cheaper price.
Do your own homework, get an mba in finance. Rely on yourself. Tell me about some of your big losers, I know you've got em. Hey brainchild, were you bying bank stocks back in 09 when it looked like the world was ending? My.125k profit.in bank srocks dwarfed anything you've come up with. Time is your greatest assett. Stocks like CELG will make you wealthy in the out years. In the mean time, don't do anything srupid.
Sentiment: Strong Buy
Thanks Rob for your effort!!
Sentiment: Strong Buy
This stock is loosing steam because of Bogus Mylan Lawsuit. The fundamentals remain over the top. This termoil will end soon, don't be late to the party. Good luck and many Happy Returns!
It has an extremely ROSEY future. Check their website and pipeline. The reason they are down is because the Mylan lawsuit is spooking investors which they have covered!! As this plays out Celg will be under pressure. I am averaging down on a regular basis. These opportunities are rare.
RBC - Markman briefing documents released, we think CELG well positioned - Otezla could be a blockbuster product given multiple indications. Reiterate Outperform and $190 target...
April 8, 2014
Markman briefing documents released, we think CELG well positioned
The public briefing documents for upcoming Markman hearing were released, email us for the PDF copies.
Markman briefing documents were released and our layman's
interpretation is that CELG is generally well positioned. In the opposition
filings, and beyond even the core fundamental arguments for the novelty
and merits of the polymorph patent and other methods patents such as
REMS system etc (CELG cites validity and infringement of 18 total patents
and additional four new ones) CELG additionally also claims or notes
NatCo has "unclean hands" (a notable defense mechanism) in part of their
belief that NatCo's had illicit methods of obtaining Revlimid for testing
and/or in their nature and part of limiting and stonewalling CELG's ability
to get key testimony from a witness involved in getting NatCo the Revlimid
for bioequivalance testing. As page 11 states "clearly Defendants have
much to fear...and are willing to go to great lengths to prevent Celgene
from obtaining his discovery."
Note recently Mylan also sued CELG claiming their inability to get access
to Revlimid outside of the REMS program in order to perform testing to
file a generic (bioequivalent) version. It is possible in our view that Mylan
was unable to initially get access or chose not via the methods that NatCo
Our call on CELG is simple: Otezla launch should be fine, consensus keeps
grinding lower now at $90M for 2014, expectations are already low on that
launch, but the big key is the result after the Markman hearing pushed
to 5/15 (from 4/29) and ruling later in summer. We think 65% chance it
rules well for the Celgene and/or a settlement could happen later this year,
and there's a big "un
Don't confuse dumb luck with excellent advice. Anyone that posts like you has probably lost more millions than have made, or is it really thousands or hundreds. Live and learn.
Only if you wan't to take out a loan to cover your losses. Shorting is playing with fire. Live and learn.
It would not surprise me. CELG trades lower PE on 2016 EPS than Merck, Pfizer, Bristol Myers. A large pharma could buy CELG for 50% premium and would be accretive. They may not get another shot at CELG for this kind of price ever again. The nuisance no merit lawsuit from Mylan will soon blow over as courts reject it (and they will). Then the charts will start "working". Then CELG will head to new highs as funds pile in at higher levels.
Just noise. Mylan is very litigious. It is their strategy. CELG has no obligation to sell their drugs to Mylan and their drugs are on patent for several more years. This is typical Mylan strategy from what I've read. The REMS has been upheld by courts so this will go nowhere for Mylan and then CELG will be loved once again. All the funds that sold low will buy back high as they always do.